Sotera Health Company (SHC) vs GeneDx Holdings Corp. (WGS)
Sotera Health Company and GeneDx Holdings Corp. are both Diagnostics & Research companies. Sotera Health Company is the larger, with a market value of $5.3B against $2.6B — 2.0× the size. GeneDx Holdings Corp. has negative trailing earnings, so its P/E is not meaningful; Sotera Health Company trades at 32.1×. GeneDx Holdings Corp. grew revenue faster over the last twelve months: 25.4% against 8.15%. Sotera Health Company has the higher net margin (13.4% vs −23.4%) and the higher return on invested capital (9.82% vs −27.7%). Across the 18 metrics below, Sotera Health Company leads on 11 and GeneDx Holdings Corp. on 7.
Valuation
Profitability
| Metric | SHC | WGS | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 54.97% | 69.37% | 50.89% |
| Operating margin | 32.82% | (20.34%) | (8.57%) |
| Net margin | 13.44% | (23.40%) | (6.37%) |
| Free cash flow margin | 9.27% | (16.68%) | 0.00% |
| Return on equity | 27.78% | (40.80%) | (2.92%) |
| Return on assets | 5.01% | (22.50%) | (6.71%) |
| Return on invested capital | 9.82% | (27.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack